Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: Tabulation of mutant enzymes

American Journal of Hematology

Volumn 51, Issue 2, 1996, Pages 122-132

  Miwa, Shiro ^a,b   Fujii, Hisaichi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Hereditary hemolytic anemia; Mutant enzymes; PK deficiency

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PYRUVATE KINASE;

ENZYME DEFICIENCY; GENE MUTATION; HEMOLYTIC ANEMIA; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030021408     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(199602)51:2<122::aid-ajh5>3.0.co;2-#     Document Type: Review

References (105)

1. Luzzatto L, Mehta A: Glucose 6-phosphate dehydrogenase deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): "The Metabolic and Molecular Basis of Inherited Disease." Ed. 7. New York: McGraw-Hill, 1995, pp 3367-3398.
2. Tanaka KR, Paglia DE: Pyruvate kinase and other enzymopathies of the erythrocyte. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): "The Metabolic and Molecular Basis of Inherited Disease." Ed. 7. New York: McGraw-Hill, 1995, pp 3485-3511.
3. Miwa S: Molecular basis of red cell enzymopathies associated with hereditary nonspherocytic hemolytic anemia. Haematologia 22:215-231, 1989.
4. Fujii H, Miwa S: Recent progress in the molecular genetic analysis of erythroenzymopathy. Am J Hematol 34:301-310, 1990.
5. 384→Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia. Proc Natl Acad Sci USA 88:8218-8221, 1991.
6. Kanno H, Fujii H, Miwa S: Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem Biophys Res Commun 188:516-523, 1992.
7. Miwa S, Kanno H, Fujii H: Concise review: Pyruvate kinase deficiency: Historical perspective and recent progress of molecular genetics. Am J Hematol 42.31-35, 1993.
8. Kanno H, Ballas SK, Miwa S, Fujii H, Bowman HS: Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish. Blood 83:2311-2316, 1994.
9. Kanno H, Fujii H, Miwa S: Molecular heterogeneity of pyruvate kinase deficiency identified by single strand conformational polymorphism (SSCP) analysis. Blood 84(suppl 1):13a, 1994.
10. Neubauer B, Lakomek M, Winkler H, Parke M, Hofferbert S, Schröter W. Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency. Blood 77:1871-1875, 1991.
11. Kanno H, Wei DCC, Miwa S, Chan LC, Fujii H: Identification of a 5′-splice site mutation and a missense mutation in homozygous pyruvate kinase deficiency cases found in Hong Kong. Blood 82(suppl 1):97a, 1993.
12. Kanno H, Fujii H, Hirono A, Omine M, Miwa S: Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia. Blood 79 1347-1350, 1992.
13. Lakomek M, Huppke P, Neubauer B, Pekrun A, Winkler H, Schröter W: Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency. Ann Hematol 68:253-260, 1994.
14. Kanno H, Wei DCC, Chan LC, Mizoguchi H, Ando M, Nakahata T, Narisawa K, Fujii H, Miwa S: Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong Kong. Blood 84:3505-3509, 1994.
15. Kanno H, Fujii H, Miwa S: Low substrate affinity of pyruvate kinase variant (PK Sapporo) due to a single amino acid substitution (426Arg→Gln) associated with hereditary hemolytic anemia. Blood 81:2439-2441, 1993.
16. Baronciani L, Beutler E: Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia. J Clin Invest 95:1702-1709, 1995.
17. Baronciani L, Beutler E: Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia. Proc Natl Acad Sci USA 90:4324-4327, 1993.
18. Lenzner C, Nürnberg P, Thiele B-J, Reis A, Brabec V, Sakalova A, Jacobasch G: Mutations in the pyruvate kinase L gene in patients with hemolytic anemia. Blood 83:2817-2822, 1994.
19. Uenaka K, Nakajima H, Noguchi T, Imamura K, Hamaguchi T, Tomita K, Yamada K, Kuwajima M, Kono N, Tanaka T, Matsuzawa Y: Compound heterozygous mutations affecting both hepatic and erythrocyte isozymes of pyruvate kinase. Biochem Biophys Res Commun 208:991-998, 1995.
20. Kanno H, Fujii H, Tsujino G, Miwa S: Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK. Biochem Biophys Res Commun 192:46-52, 1993.
21. Bianchi P, Terragna C, Zappa M, Alfinito F, Zanella A: Molecular characterization of L-PK gene in pyruvate kinase (PK) deficient Italian patients. Blood 84(suppl 1):14a, 1994.
22. Betke K, Beutler E, Brewer GJ, Kirkman HN, Luzzatto L, Motulsky AG, Ramot B, Siniscalco M: Standardization of procedures for the study of glucose-6-phosphate dehydrogenease. Report of a WHO scientific group. WHO Tech Rep Ser 366, 1967
23. Yoshida A, Lin M: Regulation of glucose-6-phosphate dehydrogenase activity in red blood cells from hemolysis and nonhemolytic variant subjects. Blood 41:877-891, 1973
24. Luzzatto L, Testa U: Human erythrocyte glucose 6 phosphate dehydrogenase. Structure and function in normal and mutant subjects. Curr Top Hematol 1:1-70, 1978.
25. Miwa S, Fujii H: Glucose-6-phosphate dehydrogenease variants in Japan. In Yoshida A, Beutler E (eds): "Glucose-6-Phosphate Dehydrogenase." Orlando, FL. Academic Press, 1986, pp 261-272.
26. Chao L, Du C-S, Louie E, Zuo L, Chen E, Lubin B, Chiu DTY: A to G substitution identified in exon 2 of the G6PD gene among G6PD deficient Chinese. Nucleic Acids Res 19:6056, 1991.
27. Chang J-G, Chiou S-S, Perng L-I, Chen T-C, Liu T-C, Lee L-S, Chen P-H, Tang TK: Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: Five mutations account for most G6PD deficiency cases in Taiwan. Blood 80:1079-1082, 1992.
28. Hirono A, Ishii A, Kere N, Fujii H, Hirono K, Miwa S: Molecular analysis of glucose-6-phosphate dehydrogenase variants in the Solomon Islands. Am J Hum Genet 56:1243-1245, 1195.
29. MacDonald D, Town M, Mason P, Vulliamy T, Luzzatto L, Goff DK: Deficiency in red blood cells. Nature 350:115, 1991.
30. Corcoran CM, Calabro V, Tamagnini G, Town M, Haidar B, Vulliamy TJ, Mason PJ, Luzzatto L: Molecular heterogeneity underlying the G6PD Mediterranean phenotype Hum Genet 88:688-690, 1992.
31. Vulliamy TJ, D'Urso M, Battistuzzi G, Estrada M, Foulkes NS, Martini G, Calabro V, Poggi V, Giordano R, Town M, Luzzatto L, Persico MG: Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci USA 85:5171-5175, 1988.
32. Hirono A, Beutler E: Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci USA 85:3951-3954, 1988.
33. Beutler E, Kuhl W, Vives-Corrons J-L, Prchal JT: Molecular heterogeneity of glucose-6-phosphate dehydrogenase A - . Blood 74:2550-2555, 1989.
34. Beutler E, Kuhl W, Ramirez E, Lisker R: Some Mexican glucose-6-phosphate dehydrogenase (G-6-PD) variants revisited Hum Genet 86:371-374, 1991.
35. Beutler E: Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 324:169-174, 1991.
36. Ganczakowski M, Town M, Bowden DK, Vulliamy TJ, Kaneko A, Clegg JB, Weatherall DJ, Luzzatto L: Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am J Hum Genet 56:294-301, 1995.
37. Vives Corrons JLI, Rovira A, Pujades A, Vulliamy T, Luzzatto L. Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) in Spain and identification of two new base substitutions in the G6PD gene. Blood 84(suppl 1):551a, 1994.
38. Vulliamy T, Beutler E, Luzzatto L: Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Hum Mutat 2:159-167, 1993.
39. Hirono A, Fujii H, Miwa S: Molecular abnormality of G6PD Konan and G6PD Ube, the most common glucose-6-phosphate dehydrogenase variants in Japan. Hum Genet 91:507-508, 1993.
40. Hirono A, Fujii H, Miwa S: Identification of two novel deletion mutations in glucose-6-phosphate dehydrogenase gene causing hemolytic anemia. Blood 85:1118-1121, 1995.
41. Maeda M, Constantoulakis P, Chen C-S, Stamatoyannopoulos G, Yoshida A: Molecular abnormalities of a human glucose-6-phosphate dehydrogenase variant associated with undetectable enzyme activity and immunologically cross-reacting material. Am J Hum Genet 51:386-395, 1992.
42. Weimer TA, Salzano FM, Westwood B, Beutler E: Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) variants from Brazil. Hum Biol 65.41, 1993.
43. Takizawa T, Yoneyama Y, Miwa S, Yoshida A: A single nucleotide base transition is the basis of the common human glucose-6-phosphate dehydrogenase variant A(+). Genomics 1:228-231, 1987.
44. Vulliamy TJ, Wanachiwanawin W, Mason PJ, Luzzatto L: G6PD Mahidol, a common deficient variant in South East Asia is caused by a (163) glycine→serine mutation. Nucleic Acids Res 17:5868, 1989.
45. Tang TK, Huang G-S, Huang M-J, Tam K-B, Tang C-CC: Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymorphism in Taiwan. Blood 79:2135, 1992.
46. Hirono A, Miwa S, Fujii H, Ishida F, Yamada K, Kubota K: Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by non-radioisotopic single-strand conformation polymorphism (SSCP) analysis. Blood 83:3363-3368, 1994.
47. Beutler E, Kuhl W: The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet 47:1008-1012, 1990.
48. De Vita G, Alcalay M, Sampietro M, Cappelini D, Fiorelli G, Toniolo D: Two point mutations are responsible for G6PD polymorphism in Sardinia. Am J Hum Genet 44:233-240, 1989.
49. Beutler E, Westwood B, Prchal J, Vaca G, Bartsocas CS, Baronciani L: New glucose-6-phosphate dehydrogenase mutations from various ethnic groups. Blood 80:255-256, 1992.
50. Calabro V, Mason PJ, Filosa S, Civitelli D, Cittadella R, Tagarelli A, Martini G, Brancati C, Luzzatto L: Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet 52:527-536, 1993.
51. Beutler E, Kuhl W, Gelbart T, Forman L: DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants. J Biol Chem 266:4145-4150, 1991.
52. Beutler E, Westwood B, Kuhl W: Definition of the mutation of G6PD Wayne, G6PD Viangchan, G6PD Jammu, and G6PD 'LeJeune.' Acta Haematol 86:179-182, 1991.
53. Poggi V, Town M, Foulkes NS, Luzzatto L: Identification of a single base change in a new human mutant glucose-6-phosphate dehydrogenase gene by polymerase-chain-reaction amplification of the entire coding region from genomic DNA. Biochem J 271:157-160, 1990.
54. Xu W, Westwood B, Bartsocas CS, Malcorra-Azpiazu JJ, Indrak K, Beutler E: Glucose-6 phosphate dehydrogenase mutations and haplotypes in various ethnic groups. Blood 85:257-263, 1995.
55. Mason PJ, Sonati MF, MacDonald D, Lanza C, Busutil D, Town M, Corcoran CM, Kaeda JS, Stevens DJ, Al-Ismail S, Altay C, Hatton C, Lewis DS, McMullin MF, Meloni T, Paul B, Pippard M, Prentice AG, Vulliamy TJ, Luzzatto L: New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia. Blood 85:1377-1380, 1995.
56. Beutler E, Westwood B, Kuhl W, Hsia YE: Glucose-6-phosphate dehydrogenase variants in Hawaii Hum Hered 42:327-329, 1992.
57. 844C: A study on its expression in blood cells and muscle. Enzyme 45:180-187, 1991.
58. Viglietto G, Montanaro V, Calabro V, Vallone D, D'Urso M, Persico MG, Battistuzzi G: Common glucose-6-phosphate dehydrogenase (G6PD) variants from the Italian population: Biochemical and molecular characterization. Ann Hum Genet 54:1-15, 1990
59. Ahluwalia A, Corcoran CM, Vulliamy TJ, Ishwad CS, Naidu JM, Argusti A, Stevens DJ, Mason PJ, Luzzatto L: G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu→Lys mutation. Hum Mol Genet 1:209-210, 1992.
60. Hirono A, Fujii H, Shima M, Miwa S: G6PD Nara: A new class 1 glucose-6-phosphate dehydrogenase variant with an eight amino acid deletion. Blood 82:3250-3252, 1993.
61. Cappellini MD, Martinez di Montemuros F, Dotti C, Tavazzi D, De Bellis G, Debernardi S, Fiorelli G: Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) Mediterranean type in Italy. Blood 84(suppl 1):114a, 1994.
62. - of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc Natl Acad Sci USA 86:10015-10017, 1989.
63. G6P and marked in vivo instability. Br J Haematol 80:111-116, 1992
64. Beutler E, Kuhl W, Saenz RGF, Rodrigues RW: Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica. Hum Genet 87:462-464, 1991.
65. Hirono A, Fujii H, Hirono K, Kanno H, Miwa S: Molecular abnormality of a Japanese glucose-6-phosphate dehydrogenase variant (G6PD Tokyo) associated with hereditary nonspherocytic hemolytic anemia. Hum Genet 88:387-388, 1991.
66. Hirono A, Nakayama S, Fujii H, Miwa S: Molecular abnormality of a unique Japanese glucose-6-phosphate dehydrogenase variant (G6PD Kobe) with an extremely increased affinity for galactose 6-phosphate. Am J Hematol 45:185-186, 1994.
67. Perng L-I, Chiou S-S, Liu T-C, Chang J-G: A novel C to T substitution at nucleotide 1360 of cDNA which abolishes a natural Hha I site accounts for a new G6PD deficiency gene in Chinese. Hum Mol Genet 1:205, 1992.
68. Vives-Corrons J-L, Kuhl W, Pujades MA, Beutler E: Molecular genetics of G6PD Mediterranean variant and description of a new mutant, G6PD Andalus 1361A. Am J Hum Genet 47:575-579, 1990.
69. Stevens DJ, Wanachiwanawin W, Mason PJ, Vulliamy TJ, Luzzatto L: G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg→Leu mutation. Nucleic Acids Res 18:7190, 1990.
70. Chiu DFY, Zuo L, Chen E, Chao L, Louie E, Lubin B, Liu TZ, Du C-S: Two commonly occurring nucleotide base substitution in Chinese G6PD variants. Biochem Biophys Res Commun 180:988, 1991.
71. Baronciani L, Tricta F, Beutler E: G6PD "Campinas": A deficient enzyme with a mutation at the far 3′ end of the gene. Hum Mutat 2:77-78, 1993.
72. Hirono A, Miwa S: Human glucose 6-phosphate dehydrogenase: Structure and function of normal and variant enzymes. Haematologia 25:85-97, 1993.
73. Mason PJ, Vulliamy TJ, Bautista IM, Luzzatto L, Naylor C, Adams M: The three dimensional structure of G6PD helps to explain G6PD deficiency. Blood 84(suppl 1):14a, 1994.
74. Bianchi M, Magnani M: Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis 21.2-8, 1995.
75. Fujii H, Kanno H, Miwa S: Identification of glucosephosphate isomerase gene mutations in two Japanese families associated with hereditary hemolytic anemia. Blood 84(suppl 1):544a, 1994.
76. Xu WM, Beutler E: The characterization of gene mutations for human glucose phosphate isomerase (GPI) deficiency associated with chronic hemolytic anemia. J Clin Invest 94:2326-2329, 1994.
77. Walker JIH, Layton DM, Bellingham AJ: DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiency. Hum Mol Genet 2:327-329, 1993.
78. Tsujino S, Servidei S, Tonin P, Shanske S, Azan G, DiMauro S: Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet 54:812-819, 1994.
79. Sherman JB, Raben N, Nicastri C, Argov Z, Nakajima H, Adams EM, Eng CM, Cowan TM, Plotz PH: Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII - and their population frequency. Am J Hum Genet 55:305-313, 1994.
80. Raben N, Exelbert R, Spiegel R, Sherman JB, Nakajima H, Plotz P, Heinisch J: Functional expression of human mutant phosphofructokinase in yeast: Genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Am J Hum Genet 56:131-141, 1995.
81. Raben N, Sherman J, Miller F, Mena H, Plotz P: A 5′ splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease). J Biol Chem 268:4963-4967, 1993.
82. Nakajima H, Kono N, Yamasaki T, Hotta K, Kawachi M, Kuwajima M, Noguchi T, Tanaka T, Tarui S: Genetic defect in muscle phosphofructokinase deficiency: Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5′-splice site. J Biol Chem 265:9392-9395, 1990.
83. Hamaguchi T, Nakajima H, Noguchi T, Ono A, Kono N, Tarui S, Kuwajima M, Matsuzawa Y: A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal splicing. Biochem Biophys Res Commun 202:444-449, 1994.
84. Raben N, Sherman JB: Mutations in muscle phosphofructokinase gene. Hum Mutat 6:1-6, 1995.
85. Kishi H, Mukai T, Hirono A, Fujii H, Miwa S, Hori K: Human aldolase A deficiency associated with a hemolytic anemia: Thermolabile aldolase due to a single base mutation. Proc Natl Acad Sci USA 84:8623-8627, 1987
86. Daar IO, Artymiuk PJ, Phillips DC, Maquat LE. Human triosephosphate isomerase deficiency. A single amino acid substitution results in a thermolabile enzyme. Proc Natl Acad Sci USA 83:7903-7907, 1986.
87. Pekrun A, Neubauer BA, Eber SE, Lakomek M, Seidel H, Schröter W. Triosephosphate isomerase deficiency, biochemical and molecular genetic analysis for prenatal diagnosis. Clin Genet 47:175-179, 1995.
88. Perry BA, Mohrenweiser HW: Human triosephosphate isomerase: Substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester. Hum Genet 88.634-638, 1992.
89. Neubauer BA, Pekrun A, Eber SW, Lakomek M, Schröter W: Relation between genetic defect, altered protein structure, and enzyme function in triosephosphate isomerase (TPI) deficiency. Eur J Pediatr 151:232a, 1992.
90. Daar IO, Maquat LE: Premature translation termination mediates triosephosphate isomerase mRNA degradation. Mol Cell Biol 8:802-813, 1988.
91. Cheng J, Maquat LE: Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA Mol Cell Biol 13:1892-1902, 1993.
92. Chang M-L, Artymiuk PJ, Wu X, Hollán S, Lammi A, Maquat LE: Human triosephosphate isomerase deficiency resulting from mutation of Phe-240. Am J Hum Genet 52:1260-1269, 1993.
93. Lemarchandel V, Jouline V, Valentin C, Rosa R, Galacteros F, Rosa J, Cohen-Solal M: Compound heterozygosity in a complete erythrocytc bisphosphoglycerate mutase deficiency. Blood 80:2643-2649, 1992.
94. Maeda M, Yoshida A: Molecular defect of a phosphoglycerate kinase variant (PGK-Matsue) associated with hemolytic anemia: Leu→Pro substitution caused by T/A→C/G transition in exon 3. Blood 77:1348-1352, 1991.
95. Tsujino S, Tonin P, Shanske S, Nohria V, Boustany R-M, Lewis D, Chen Y-T, DiMauro S: A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann Neurol 35:349-353, 1994.
96. Fujii H, Kanno A, Hirono A, Shiomura T, Miwa S: A single amino acid substitution (157 Gly→Val) in a phosphoglycerate kinase variant (PGK Shizuoka) associated with chronic hemolysis and myoglobinuria. Blood 79:1582-1585, 1992.
97. Cohen-Solal M, Valentin C, Plassa F, Guillemin G, Danze F, Jaisson F, Rosa R: Identification of new mutations in two phosphoglycerate kinase variants expressing different clinical syndromes: PGK Creteil and PGK Amiens. Blood 82(suppl 1):97a, 1993.
98. Fujii H, Yoshida A: Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia. Proc Natl Acad Sci USA 77:5461-5465, 1980.
99. Fujii H, Chen S-H, Akatsuka J, Miwa S, Yoshida A: Use of cultured lymphoblastoid cells for the study of abnormal enzymes: Molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia. Proc Natl Acad Sci USA 78:2587-2590, 1981.
100. Fujii H, Krietsch WKG, Yoshida A. A single amino acid substitution (Asp→Asn) in a phosphoglycerate kinase variant (PGK München) associated with enzyme deficiency. J Biol Chem 255:6421-6423, 1980.
101. Maeda M, Bawle EV, Kulkami R, Beutler E, Yoshida A: Molecular abnormality of a phosphoglycerate kinase variant generated by spontaneous mutation. Blood 79:2759-2762, 1992.
102. Yoshida A, Watanabe S, Chen S-H, Giblett ER, Malcolm LA: Human phosphoglycerate kinase. II. Structure of a variant enzyme. J Biol Chem 247:446-449, 1972.
103. Matsuura S, Igarashi M, Tanizawa Y, Yamada M, Kishi F, Kajii T, Fujii H, Miwa S, Sakurai M, Nakazawa A: Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of cytosolic adenylate kinase. J Biol Chem 264:10148-10155, 1989.
104. Hirono A, Fujii H, Natori H, Kurokawa I, Miwa S: Chromatographic analysis of human erythrocyte pyrimidine 5′-nucleotidase from five patients with pyrimidine 5′-nucleotidase deficiency. Br J Haematol 65:35-41, 1987.
105. Chen EH, Tartaglia AP, Mitchell BS: Hereditary overproduction of adenosine deaminase in erythrocytes: Evidence for a cis-acting mutation. Am J Hum Genet 53:889-893, 1993.